Deanna Acosta, Ph.D. - Publications
Affiliations: | 2013 | Genetics | Yeshiva University, New York, NY, United States |
Area:
Genetics, Human Development, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2021 | Gao Y, Kabotyanski EB, Shepherd JH, Villegas E, Acosta D, Hamor C, Sun T, Montmeyor-Garcia C, He X, Dobrolecki LE, Westbrook TF, Lewis MT, Hilsenbeck SG, Zhang XH, Perou CM, et al. Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics. Cancer Research Communications. 1: 178-193. PMID 35156101 DOI: 10.1158/2767-9764.crc-21-0106 | 0.359 | |||
2016 | Acosta D, Bagchi S, Broin PÓ, Hollern D, Racedo SE, Morrow B, Sellers RS, Greally JM, Golden A, Andrechek E, Wood T, Montagna C. LPA receptor activity is basal specific and coincident with early pregnancy and involution during mammary gland postnatal development. Scientific Reports. 6: 35810. PMID 27808166 DOI: 10.1038/Srep35810 | 0.447 | |||
2011 | Acosta D, Suzuki M, Connolly D, Thompson RF, Fazzari MJ, Greally JM, Montagna C. DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 22: 249-59. PMID 21373886 DOI: 10.1007/S00335-011-9318-6 | 0.377 | |||
Show low-probability matches. |